Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection

Invasive fungal infections (IFI) are a heterogeneous group of diseases, whose clinical significance is increased due to large number of cancerpatients, patients with aplastic anemia, congenital or acquired immunity defects. Morbidity and mortality due to fungal infection remain high, and the availab...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Pirumovav, M. S. Gelfand
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/53
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850023085208502272
author V. P. Pirumovav
M. S. Gelfand
author_facet V. P. Pirumovav
M. S. Gelfand
author_sort V. P. Pirumovav
collection DOAJ
description Invasive fungal infections (IFI) are a heterogeneous group of diseases, whose clinical significance is increased due to large number of cancerpatients, patients with aplastic anemia, congenital or acquired immunity defects. Morbidity and mortality due to fungal infection remain high, and the available diagnostic methods do not always allow timely detect and isolate infection pathogen. Microbiological and histological examination of biopsy material is the “gold standard” of IFI diagnostic, but in practice it is often associated with high risk for patients. Reliable nonculture methods of early IFI detection needed to improve current diagnostic and allowing an earlier decision of specific antifungal therapy. This article presents the advantages and limitations of one of these tests. In recent years, many articles and reviews about circulating (1→3)β-D-glucan (BDG) detection (major cell wall component of most pathogenic fungi) has appeared in the available literature. Despite that this test has a high diagnostic value, to recommend it for routine use in children with febrile neutropenia is premature. This test is less useful in making timely decision about diagnosis and start of antifungal therapy because of moderate sensitivity and specificity, the lack of evaluation criteria in children, late results (if detected in reference laboratory) and cost. BDG detection results can be interpreted only in conjunction with clinical course and data of routine laboratory and radiological methods.
format Article
id doaj-art-e8156d9d90d346889fce1c4129dacadb
institution DOAJ
issn 1818-8346
2413-4023
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-e8156d9d90d346889fce1c4129dacadb2025-08-20T03:01:29ZrusABV-pressОнкогематология1818-83462413-40232014-07-0173434810.17650/1818-8346-2012-7-3-369-37468Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infectionV. P. Pirumovav0M. S. Gelfand1Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaHealth Science Center, The University of TennesseeInvasive fungal infections (IFI) are a heterogeneous group of diseases, whose clinical significance is increased due to large number of cancerpatients, patients with aplastic anemia, congenital or acquired immunity defects. Morbidity and mortality due to fungal infection remain high, and the available diagnostic methods do not always allow timely detect and isolate infection pathogen. Microbiological and histological examination of biopsy material is the “gold standard” of IFI diagnostic, but in practice it is often associated with high risk for patients. Reliable nonculture methods of early IFI detection needed to improve current diagnostic and allowing an earlier decision of specific antifungal therapy. This article presents the advantages and limitations of one of these tests. In recent years, many articles and reviews about circulating (1→3)β-D-glucan (BDG) detection (major cell wall component of most pathogenic fungi) has appeared in the available literature. Despite that this test has a high diagnostic value, to recommend it for routine use in children with febrile neutropenia is premature. This test is less useful in making timely decision about diagnosis and start of antifungal therapy because of moderate sensitivity and specificity, the lack of evaluation criteria in children, late results (if detected in reference laboratory) and cost. BDG detection results can be interpreted only in conjunction with clinical course and data of routine laboratory and radiological methods.https://oncohematology.abvpress.ru/ongm/article/view/53invasive fungal infectioncirculating (1→3)β-d-glucanbeta-glucan test
spellingShingle V. P. Pirumovav
M. S. Gelfand
Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
Онкогематология
invasive fungal infection
circulating (1→3)β-d-glucan
beta-glucan test
title Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
title_full Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
title_fullStr Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
title_full_unstemmed Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
title_short Clinical value of blood circulating (1→3)β-D-glucan in patients with suspected invasive fungal infection
title_sort clinical value of blood circulating 1 3 β d glucan in patients with suspected invasive fungal infection
topic invasive fungal infection
circulating (1→3)β-d-glucan
beta-glucan test
url https://oncohematology.abvpress.ru/ongm/article/view/53
work_keys_str_mv AT vppirumovav clinicalvalueofbloodcirculating13bdglucaninpatientswithsuspectedinvasivefungalinfection
AT msgelfand clinicalvalueofbloodcirculating13bdglucaninpatientswithsuspectedinvasivefungalinfection